HIGHLIGHTS
- who: Top from the Pathology Department, Fundación Jiménez Díaz, UAM, Madrid, Spain have published the research work: Overlap at the molecular and immunohistochemical levels, in the Journal: (JOURNAL)
- how: Library preparation and sequencing For targeted sequencing the authors used 30 ng DNAg and the Ion AmpliSeq™ custom panel technology (Life Technologies) following the standard protocol.
SUMMARY
Accordingly, 89.7% (61/68) of the cases had a TFH phenotype when only 10% of tumoral cells (defined as atypical T-cells) expressed at least two of the markers studied (TFH . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.